A drug made from chemicals found in marijuana has entered human trials as a treatment for schizophrenia. GW Pharmaceuticals announced on Monday that it has started Phase 2 clinical trials on a drug made from the marijuana compound cannabidiol (CBD).
Categories: Best of the Web, Cannabis Facts, Marijuana News, Medical Marijuana
Tags: cancer, cbd, diabetes, epilepsy, GW Pharmaceuticals, patients.
By:
Chuck Finley. Permalink: 
Shortlink: http://weedi.st/aV1YR
Tags: cancer, cbd, diabetes, epilepsy, GW Pharmaceuticals, patients.
By:
Chuck Finley. Permalink: Shortlink: http://weedi.st/aV1YR